soul trial oral semaglutide cardiovascular outcomes 2024 and in Patients with Type 2 Diabetes soul trial oral semaglutide cardiovascular

Kureshis commitment to personalized care

This is especially crucial with GLP-1s for weight loss due to the potential for reduced thirst and the need for adequate hydration to support fibers action and overall gut health while on GLP-1

The proportion of smokers and drinkers showed no significant differences between the two groups

They were also shown to prevent kidney function decline in DM patients after AMI [17]

This 3-month window after transplant serves to mitigate reverse causality effects, ensuring that outcomes are more reliably attributed to the use of GLP-1RA

They didnt eat just a little less, they ate a lot less over 60% less